Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Anderson said clinical trial data shows the pill is as effective as the injectable version
Boost your burn with this metabolic-boosting trio
The most commonly reported side effects include: Nausea : Affecting 12% to 24% of patients with type 2 diabetes and 24% to 31% in weight management trials [1] [14] Diarrhea : 12% to 17% in diabetes trials and 18% to 23% in weight management trials Decreased appetite : 5% to 10% of patients Vomiting : 5% to 10% in diabetes trials and 8% to 12% in weight management trials Constipation : 5% to 7% in diabetes trials and 16% to 17% in weight management trials Dyspepsia : 5% to 9% of patients Abdominal pain : 5% to 9% of patients Alopecia (hair loss) : Reported in weight management trials These symptoms are typically mild to moderate in severity, occur most commonly during dose escalation, and tend to diminish over time as patients develop tolerance
8.4 Pediatric Use PEDIATRIC USE SECTION The safety and effectiveness of MOUNJARO as an adjunct to diet and exercise to improve glycemic control in pediatric patients 10 years of age and older with type 2 diabetes mellitus have been established
US$ 22.01
US$ 21.26
US$ 28.24
US$ 27.50
US$ 29.92
